Clinical Research Directory

Patient Participant Inclusion Criteria: * Adults aged ≥25 years * Stage 2 hypertension defined as either: * Systolic Blood Pressure (SBP) ≥160 mmHg at screening (Group A); OR * SBP 140-159 mmHg at screening with either documented elevation on more than one visit or a known history of hypertension (e.g., prior clinician diagnosis or current use of antihypertensive medication) (Group B) Patient Participant Exclusion Criteria: * \<25 years of age * Hypertensive emergency with SBP ≥180 mmHg at screening (these patients will be referred to the nearest health center per local protocol; they may be re-screened for eligibility at a subsequent visit if SBP meets the inclusion criteria above) * Diagnosis of end-stage renal disease (ESRD) * Condition which interferes with outcome measurement (e.g., dialysis) * Serious medical condition which either limits life expectancy or requires active management (e.g., certain cancers) * Cognitive impairment or other condition preventing participation in the intervention * Active alcohol or substance use disorder (i.e., not sober/abstinent for ≥30 days), screened using the NIAAA Single Alcohol Screening Question * Pregnant or planning pregnancy in the next 24 months * Currently nursing a child * Current participation in another research study focused on reducing blood pressure * Current participation in a care management program related to health conditions (e.g., weight reduction, smoking cessation) * Planning to move out of the geographic area within 7 months * Unwillingness to provide informed consent Community Health Nurse (CHN) Participant Inclusion Criteria: * CHNs who were directly involved in delivering the nurse-led community-based hypertension intervention * Willing to provide oral informed consent for participation in pre/post-training surveys and semi-structured interviews Community Health Nurse (CHN) Participant Exclusion Criteria: * CHNs who were not directly involved in the delivery of the intervention